by Nicolas Oberndorfer | Feb 16, 2021 | Dermapharm Ad-Hoc News, News, Uncategorized
Ad hoc news to the archive Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021 Grünwald, February 12, 2021 – Dermapharm Holding SE (WKN: A2GS5D, ISIN:...
by Nicolas Oberndorfer | Sep 10, 2020 | Dermapharm Ad-Hoc News, News
Ad hoc news to the archive Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE Grünwald, September 10, 2020 – Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8) and BioNTech SE, Mainz, Germany, have agreed that their production...
by Nicolas Oberndorfer | Feb 8, 2018 | Dermapharm Ad-Hoc News, News
Ad hoc news to the archive Dermapharm Holding SE sets offer price at EUR 28.00 per share Grünwald, February 8, 2018 – Today, Dermapharm Holding SE (together with its consolidated subsidiaries, “Dermapharm”, ISIN: DE000A2GS5D8) and the selling...
